NCT05261386View on ClinicalTrials.gov

Safety, Efficacy and Pharmacokinetics of CBT-008 in Patients With Meibomian Gland Dysfunction

PHASE2CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

March 4, 2022

Primary Completion Date

September 7, 2022

Study Completion Date

March 29, 2023

Conditions
Meibomian Gland Dysfunction
Interventions
DRUG

CBT-008

Treat MGD

Trial Locations (1)

92663

David Research Wirta, Newport Beach

Sponsors
All Listed Sponsors
lead

Cloudbreak Therapeutics, LLC

INDUSTRY